Hypophosphatemia-factors associated with its development and 90-day mortality effect: a prospective observational

Liran Statlender1,2, Tzippy Shochat3, Limor Rozilyo4

  • 1Department of General Intensive Care, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel.

Frontiers in Medicine
|July 14, 2026
PubMed

Insights

Critically ill patients with hypophosphatemia showed altered phosphate renal handling, specifically in creatinine clearance and tubular reabsorption. Restrictive energy delivery was not linked to hypophosphatemia.

Area of Science:

  • Critical Care Medicine
  • Nephrology
  • Intensive Care Unit (ICU) Management

Background:

  • Hypophosphatemia is common in critically ill patients, but data on energy delivery and renal phosphate handling are limited.
  • Understanding factors influencing hypophosphatemia is crucial for optimizing patient care in the ICU.

Purpose of the Study:

  • To investigate the relationship between restrictive energy delivery, phosphate renal handling, and the development of hypophosphatemia in critically ill patients.
  • To identify predictors of hypophosphatemia and its association with 90-day mortality.

Main Methods:

  • Observational study of 181 ventilated ICU patients with stays >48 hours.
  • Daily monitoring of serum phosphate, energy/phosphate delivery, fluid balance, and 6-hour urine collections for creatinine and phosphate.
  • Calculation of creatinine clearance (CrCl6hr), tubular reabsorption of phosphate (TRP), and TmP/GFR; regression analyses for hypophosphatemia and mortality.

Main Results:

  • 60.22% of patients developed hypophosphatemia.
  • No association found between energy delivery and hypophosphatemia.
  • Multivariate analysis linked hypophosphatemia to log of CrCl6hr and TmP/GFR, not energy delivery.

Conclusions:

  • Phosphate renal handling, measured by CrCl6hr and TmP/GFR, is associated with hypophosphatemia in critically ill patients.
  • Energy delivery was not associated with hypophosphatemia.
  • While hypophosphatemia showed univariate association with mortality, it was not significant in multivariate analysis; age and APACHE2 score were mortality predictors.
Abstract

Related Concept Videos

Peritoneal Dialysis III: Nursing Management01:25

Peritoneal Dialysis III: Nursing Management

Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

Factors Affecting Protein-Drug Binding: Patient-Related Factors

Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).